210 related articles for article (PubMed ID: 11319230)
21. Redirecting therapeutic T cells against myelin-specific T lymphocytes using a humanized myelin basic protein-HLA-DR2-zeta chimeric receptor.
Moisini I; Nguyen P; Fugger L; Geiger TL
J Immunol; 2008 Mar; 180(5):3601-11. PubMed ID: 18292588
[TBL] [Abstract][Full Text] [Related]
22. Rationally designed mutations convert complexes of human recombinant T cell receptor ligands into monomers that retain biological activity.
Huan JY; Meza-Romero R; Mooney JL; Chou YK; Edwards DM; Rich C; Link JM; Vandenbark AA; Bourdette DN; Bächinger HP; Burrows GG
J Chem Technol Biotechnol; 2005 Jan; 80(1):2-12. PubMed ID: 22973070
[TBL] [Abstract][Full Text] [Related]
23. Separation of complexes of major histocompatibility class II molecules and known antigenic peptide by metal chelate affinity chromatography.
Nag B; Mukku PV; Arimilli S; Kendrick T; Deshpande SV; Sharma SD
J Immunol Methods; 1994 Mar; 169(2):273-85. PubMed ID: 7510762
[TBL] [Abstract][Full Text] [Related]
24. Degenerate TCR recognition and dual DR2 restriction of autoreactive T cells: implications for the initiation of the autoimmune response in multiple sclerosis.
Zhang X; Tang Y; Sujkowska D; Wang J; Ramgolam V; Sospedra M; Adams J; Martin R; Pinilla C; Markovic-Plese S
Eur J Immunol; 2008 May; 38(5):1297-309. PubMed ID: 18412170
[TBL] [Abstract][Full Text] [Related]
25. Myelin autoreactivity in multiple sclerosis: recognition of myelin basic protein in the context of HLA-DR2 products by T lymphocytes of multiple-sclerosis patients and healthy donors.
Pette M; Fujita K; Wilkinson D; Altmann DM; Trowsdale J; Giegerich G; Hinkkanen A; Epplen JT; Kappos L; Wekerle H
Proc Natl Acad Sci U S A; 1990 Oct; 87(20):7968-72. PubMed ID: 1700423
[TBL] [Abstract][Full Text] [Related]
26. Kinetics of T-cell receptor binding by bivalent HLA-DR. Peptide complexes that activate antigen-specific human T-cells.
Appel H; Gauthier L; Pyrdol J; Wucherpfennig KW
J Biol Chem; 2000 Jan; 275(1):312-21. PubMed ID: 10617620
[TBL] [Abstract][Full Text] [Related]
27. Predominant and stable T cell responses to regions of myelin basic protein can be detected in individual patients with multiple sclerosis.
Salvetti M; Ristori G; D'Amato M; Buttinelli C; Falcone M; Fieschi C; Wekerle H; Pozzilli C
Eur J Immunol; 1993 Jun; 23(6):1232-9. PubMed ID: 7684682
[TBL] [Abstract][Full Text] [Related]
28. Naturally processed HLA class II peptides reveal highly conserved immunogenic flanking region sequence preferences that reflect antigen processing rather than peptide-MHC interactions.
Godkin AJ; Smith KJ; Willis A; Tejada-Simon MV; Zhang J; Elliott T; Hill AV
J Immunol; 2001 Jun; 166(11):6720-7. PubMed ID: 11359828
[TBL] [Abstract][Full Text] [Related]
29. HLA-DR2a is the dominant restriction molecule for the cytotoxic T cell response to myelin basic protein in DR2Dw2 individuals.
Jaraquemada D; Martin R; Rosen-Bronson S; Flerlage M; McFarland HF; Long EO
J Immunol; 1990 Nov; 145(9):2880-5. PubMed ID: 1698864
[TBL] [Abstract][Full Text] [Related]
30. HLA-DR2 haplotypic diversity in populations of South-East Asia, northern China, Melanesia and Australian aborigines using PCR-RFLP for DRB1, DRB5, DQA1 and DQB1. A novel DRB1 allele: DRB1*16022.
Trejaut J; Bhatia K; Greville WD; Hu KR; Duraisamy G; Nuchprayoon C; Donald J; Aziz A; Dunckley H
Eur J Immunogenet; 1996 Dec; 23(6):437-49. PubMed ID: 8971541
[TBL] [Abstract][Full Text] [Related]
31. Molecular characterization of a recombinant HLA-DR1/DR2 haplotype.
Bidwell JL; Bidwell EA; Dupont E; Andrien M; Bouillenne C; Klouda PT; Bradley BA
Hum Immunol; 1992 Apr; 33(4):289-93. PubMed ID: 1353488
[TBL] [Abstract][Full Text] [Related]
32. HLA-DR4-IE chimeric class II transgenic, murine class II-deficient mice are susceptible to experimental allergic encephalomyelitis.
Ito K; Bian HJ; Molina M; Han J; Magram J; Saar E; Belunis C; Bolin DR; Arceo R; Campbell R; Falcioni F; Vidović D; Hammer J; Nagy ZA
J Exp Med; 1996 Jun; 183(6):2635-44. PubMed ID: 8676084
[TBL] [Abstract][Full Text] [Related]
33. Redundancy in antigen-presenting function of the HLA-DR and -DQ molecules in the multiple sclerosis-associated HLA-DR2 haplotype.
Sospedra M; Muraro PA; Stefanová I; Zhao Y; Chung K; Li Y; Giulianotti M; Simon R; Mariuzza R; Pinilla C; Martin R
J Immunol; 2006 Feb; 176(3):1951-61. PubMed ID: 16424227
[TBL] [Abstract][Full Text] [Related]
34. Structure of a human autoimmune TCR bound to a myelin basic protein self-peptide and a multiple sclerosis-associated MHC class II molecule.
Li Y; Huang Y; Lue J; Quandt JA; Martin R; Mariuzza RA
EMBO J; 2005 Sep; 24(17):2968-79. PubMed ID: 16079912
[TBL] [Abstract][Full Text] [Related]
35. Regulation of encephalitogenic T cells with recombinant TCR ligands.
Burrows GG; Adlard KL; Bebo BF; Chang JW; Tenditnyy K; Vandenbark AA; Offner H
J Immunol; 2000 Jun; 164(12):6366-71. PubMed ID: 10843691
[TBL] [Abstract][Full Text] [Related]
36. TCR-like antibodies distinguish conformational and functional differences in two- versus four-domain auto reactive MHC class II-peptide complexes.
Dahan R; Tabul M; Chou YK; Meza-Romero R; Andrew S; Ferro AJ; Burrows GG; Offner H; Vandenbark AA; Reiter Y
Eur J Immunol; 2011 May; 41(5):1465-79. PubMed ID: 21469129
[TBL] [Abstract][Full Text] [Related]
37. Serologic and molecular studies of two kindreds expressing recombinant HLA DR1/DR2 haplotypes.
Wisecarver J; Shepherd S; Beisel K; Rubocki R
Tissue Antigens; 1993 Mar; 41(3):148-54. PubMed ID: 7686308
[TBL] [Abstract][Full Text] [Related]
38. Increasing complexity of HLA-DR2 as detected by serology and oligonucleotide typing.
Schreuder GM; van den Berg-Loonen PM; Verduyn W; Geraets DP; Parlevliet J; van Rood JJ; Giphart MJ
Hum Immunol; 1991 Oct; 32(2):141-9. PubMed ID: 1683866
[TBL] [Abstract][Full Text] [Related]
39. Antigenic peptide binding to MHC class II molecules at increased peptide concentrations.
Nag B; Mukku PV; Arimilli S; Phan D; Deshpande SV; Winkelhake JL
Mol Immunol; 1994 Oct; 31(15):1161-8. PubMed ID: 7523870
[TBL] [Abstract][Full Text] [Related]
40. On the relative immunogenicity of DR alloantigens: T cell recognition of HLA-DR2a and HLA-DR2b.
Rosen-Bronson S; Jaraquemada D
Hum Immunol; 1991 Mar; 30(3):215-21. PubMed ID: 2055786
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
